Lifecome Biochemistry Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 3, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Dec '21 Dec 31, 2021
Market Capitalization	3,500	5,239	3,104	3,261	8,144	1,692
Market Cap Growth	-15.11%	68.80%	-4.84%	-59.96%	381.32%	-17.32%
Enterprise Value	3,919	6,325	4,110	3,952	8,399	1,846
Last Close Price	22.52	33.71	19.97	21.26	53.09	11.03
PS Ratio	7.44	10.14	4.78	6.43	24.69	4.66
PB Ratio	48.37	80.69	-126.49	7.88	13.59	2.34
P/TBV Ratio	70.19	124.44	-	15.00	14.43	2.50
P/FCF Ratio	-	-	189.81	-	-	-
P/OCF Ratio	-	-	21.95	-	-	48.11
EV/Sales Ratio	8.33	12.24	6.33	7.80	25.46	5.08
EV/EBITDA Ratio	94.75	557.77	-	-	-	92.74
EV/FCF Ratio	-	-	251.38	-	-	-
Debt / Equity Ratio	6.49	7.82	-38.70	2.62	0.66	0.45
Debt / EBITDA Ratio	11.34	35.37	-	-	-	16.07
Debt / FCF Ratio	-	-	58.08	-	-	-
Net Debt / Equity Ratio	5.78	6.96	-37.69	2.42	0.62	0.31
Net Debt / EBITDA Ratio	10.10	39.85	-8.12	-8.17	-7.07	11.24
Net Debt / FCF Ratio	-2.34	-2.92	56.56	-1.54	-2.54	-0.69
Asset Turnover	0.44	0.46	0.38	0.32	0.26	0.33
Inventory Turnover	4.35	5.24	5.08	4.21	5.08	5.43
Quick Ratio	0.20	0.18	0.10	0.29	0.18	0.42
Current Ratio	0.37	0.35	0.17	0.51	1.04	0.58
Return on Equity (ROE)	-	-689.73%	-228.96%	-43.93%	-18.57%	-3.55%
Return on Assets (ROA)	-1.58%	-4.66%	-7.62%	-7.49%	-5.84%	-0.78%
Return on Invested Capital (ROIC)	-6.42%	-21.81%	-25.31%	-16.08%	-12.18%	-1.74%
Return on Capital Employed (ROCE)	-14.70%	-55.10%	-84.70%	-18.60%	-15.50%	-1.60%
Earnings Yield	-2.10%	-2.66%	-14.33%	-6.80%	-1.50%	-1.54%
FCF Yield	-5.10%	-2.96%	0.53%	-19.97%	-1.80%	-19.03%
Buyback Yield / Dilution	0.51%	0.52%	-0.98%	0.20%	-0.75%	0.72%
Total Shareholder Return	0.51%	0.52%	-0.98%	0.20%	-0.75%	0.72%